510(k) K062347

ASCENSIA BREEZE 2 BLOOD GLUCOSE MONITORING SYSTEM by Bayer Healthcare, LLC — Product Code NBW

K062347 is an FDA 510(k) premarket notification submitted by Bayer Healthcare, LLC for the device "ASCENSIA BREEZE 2 BLOOD GLUCOSE MONITORING SYSTEM". The FDA issued a decision of Substantially Equivalent on November 22, 2006. The device falls under product code NBW (System, Test, Blood Glucose, Over The Counter), a Class II device regulated under 21 CFR 862.1345. Bayer Healthcare, LLC has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
November 22, 2006
Date Received
August 10, 2006
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
System, Test, Blood Glucose, Over The Counter
Device Class
Class II
Regulation Number
862.1345
Review Panel
CH
Submission Type